Giant right plantar keloid treated with excision and tissue-engineered allograft

Journal of the American Academy of Dermatology

Volumn 48, Issue 1, 2003, Pages 131-134

  Osswald, Sandra S ^a   Elston, Dirk M ^a   Vogel, Paula S ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; TRIAMCINOLONE ACETONIDE;

ADULT; ALLOGRAFT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; KELOID; MALE; MOBILIZATION; PAIN; PRIORITY JOURNAL; SILICONE PROSTHESIS; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 0037233943     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.48     Document Type: Article

References (17)

1. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995;33:117-23.
2. Niessen FB, Spauwen PHM, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:1435-58.
3. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg 1999;25:631-8.
4. Haas AF, Reilly DA. Cultured epithelial autografts in the treatment of extensive recalcitrant keloids. Arch Dermatol 1998;134:549-52.
5. Falanga VJ. Tissue engineering in wound repair. Adv Skin Wound Care 2000;13:15-9.
6. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000;136:1225-30.
7. Falanga V, Sabolinski M. A bilayered living skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999;7:201-7.
8. Eaglstein WH, Alvarez OM, Auletta M, Leffel D, Rogers GS, Zitelli JA, et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg 1999;25:195-201.
9. De Imus G, Golomb C, Wilkel C, T soukas M, Nowak M, Falanga V. Accelerated healing-of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001;44:61-6.
10. Phillips TJ. New skin for old: developments in biological skin substitutes [editorial]. Arch Dermatol 1998;134:344-9.
11. Trent JF, Kirsner RS. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract 1998;52:408-13.
12. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998;134:293-300.
13. Sandier B. Recurrent plantar keloid. Cutis 1999;63:325-6.
14. Brem H, Balledux J, Bloom T, Kerstein MD, Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent:a new paradigm in wound healing. Arch Surg 2000;135:627-34.
15. Lim IJ, Phan TT, Song C, Tan WTL, Longaker MT. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 2001;107:797-808.
16. Ishihara H, Yoshimoto H, Fujioka M, Murakami R, Hirano A, Fujii T, et al. Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 2000;115:1065-71.
17. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-16.